Clinical trial
Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake…
NCT00249405 · University of Cincinnati, Other · Completed
Key facts
| NCT number | NCT00249405 |
|---|---|
| Title | Predicting Alcoholics' Treatment Responses to a Selective Serotonin Re-uptake Inhibitor (SSRI) |
| Official title | Predicting Alcoholics' Treatment Responses to an SSRI |
| Lead sponsor | University of Cincinnati, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism, Alcohol Abuse |
| Intervention type | Behavioral, Drug |
| Interventions | Citalopram + MI, Placebo + MI |
| Enrollment | 200 |
| Start date | Feb 1, 2005 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Nov 7, 2005 |
| Last update posted | Nov 3, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: